Cell and Gene Therapy
5 Things To Know About Hemophilia B
Hemophilia B patients are missing clotting Factor IX but treatments have come a long way - with more innovation in progress.
Gene Therapy Collaboration with Seattle Children’s
CSL Behring’s R&D Head: We’re growing our capabilities in gene therapy to improve patients’ lives.
Celebrating an Expanded R&D Facility in Pasadena
CSL Behring site includes three labs and cell manufacturing space near leading academic institutions.
Patients as Partners
Healthcare panel will explore how tech can build a bridge and involve patients every step of the way.